Skip to content
IMNM·Nasdaq·US

Immunome

Immunome is a US biotechnology company focused on developing oncology therapeutics, including antibody-drug conjugates, radioligand therapies, and other cancer drug candidates. It also has a discovery platform and strategic partnerships that support its pipeline development.

Thematic Position

IMNM

Relationship Groups

Partners1
Licensing2
Competitors16

Relationship details are part of the Pro plan.

Ended Relationships

8 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

tarifftrade restrictionexport control
U.S. tariffs and foreign retaliatory tariffs disrupting pharmaceutical supply chain
SEC 10-QAug 11, 2026

The full regulatory passage is part of the Pro plan.

16 more · Regulatory and geopolitical insights are part of the Pro plan.